Grants and Contributions:

Title:
CIIP Korea Project 3D Printing Therapy
Agreement Number:
938664
Agreement Value:
$581,851.00
Agreement Date:
Oct 28, 2019 - Oct 31, 2021
Description:
CIIP Korea project 3D Printing Therapy will integrate unique 3D bioprinting technology from Aspect Biosystems Ltd. (Canada) with pluripotent stem cell technology from NEXEL Co., Ltd. (Korea) and tissue engineering technologies from POSTECH (Korea). Together, this international team will create a comprehensive solution for 3D bioprinting implantable cardiac and pancreatic therapeutic tissues containing validated stem cell-derived cells as an important step towards the future treatment of patients with myocardial infarction or Type-1 Diabetes.
Organization:
National Research Council Canada
Expected Results:

The Canadian International Innovation Program fosters and supports collaborative industrial research and development projects with high potential for commercialization between Canada and partner countries. It also stimulates bilateral science and technology networking and matchmaking activities to further new partnerships and accelerate the commercialization of research and development.

Location:
Vancouver, British Columbia, CA V6P 6P2
Reference Number:
172-2019-2020-Q3-938664
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
830167839
Recipient Type:
For-profit organization
Additional Information:

This agreement has been amended 1 time(s). The total amended value is -18,149 dollars.

Amendment Date
Mar 31, 2020
Recipient's Legal Name:
Aspect Biosystems Ltd.
Federal Riding Name:
Vancouver Quadra
Federal Riding Number:
59039
Program:
Canadian International Innovation Program
Program Purpose:

The Canadian International Innovation Program fosters and supports collaborative industrial research and development projects with high potential for commercialization between Canada and partner countries. It also stimulates bilateral science and technology networking and matchmaking activities to further new partnerships and accelerate the commercialization of research and development.

Coverage:
The Canadian International Innovation Program supports industrial R & D partnerships and matchmaking activities between Canadian companies and foreign partners with a view to accelerating commercialization and facilitating market access.
NAICS Code:
541710
Amendments: